NCT06935487 - European Multicenter Validation of PCaVision: A Head-to-Head Diagnostic Accuracy Study Comparing Multiparametric Transrectal Ultrasound to MRI for Clinically Significant Prostate Cancer Detection | Biotech Hunter

Enrollment

806

Participants

Timeline

Start Date

April 1, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

May 31, 2027

Conditions

Prostate Cancer

Interventions

DIAGNOSTIC_TEST

transrectal ultrasound of prostate (TRUS) with AI software algorithm

Transrectal ultrasound of prostate (TRUS) with AI software algorithm for detection of lesions suspected for prostate cancer

DIAGNOSTIC_TEST

MRI prostate

MRI for detection of lesions suspected for prostate cancer

Trial Locations (10)

Institut Paoli- Calmettes, Marseille

L'Institut Mutualiste Montsouris, Paris

University Klinikum Bonn, Bonn

Martini-Klinik am UKE, Hamburg

Urologische Klinik München- Planegg, Planegg

Università degli Studi di Foggia, Foggia

University of Padua, Padua

Amsterdam UMC, Amsterdam

Oslo University hospital Ullevål, Oslo

Fundació Puigvert, Barcelona